ASTRAZENECA PLC (AZN)
Clinical trial NCT06427876 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06427876 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04522544: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT03016338 updates: 1. status: UNKNOWN → ACTIVE_NOT_RECRUITING 2. completion date: 2025-12-01 → 2026-12-01
Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Companys Proprietary DIFS™ Platform
Clinical trial NCT03836209: completion date: 2026-12-01 → 2026-07-01.
Clinical trial NCT07615192 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-26 → 2026-05-29
Clinical trial NCT04181827: completion date: 2029-04-09 → 2027-03-31.
Clinical trial NCT07519772 updates: 1. completion date: 2030-10-21 → 2031-04-01 2. primary completion date: 2030-01-20 → 2030-07-01
Clinical trial NCT07357831: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Press Release: DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction